Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centratama Telekomunikasi Indonesia Tbk. (CENT) vs Sinergi Multi Lestarindo Tbk. (SMLE) Price & Performance

Centratama Telekomunikasi Indonesia Tbk.Trade
Sinergi Multi Lestarindo Tbk.Trade

Price performance (Past 24H)

Key statistics

Centratama Telekomunikasi Indonesia Tbk. vs Sinergi Multi Lestarindo Tbk. — how do they compare? Centratama Telekomunikasi Indonesia Tbk. trades at Rp74 (market cap 2.34T, 535.2K 24h volume), while Sinergi Multi Lestarindo Tbk. trades at Rp128 (market cap 302.66B, 13.94M 24h volume). The key difference: Centratama Telekomunikasi Indonesia Tbk. is far larger — about 7.7× Sinergi Multi Lestarindo Tbk.'s market cap, and Sinergi Multi Lestarindo Tbk. is more actively traded (13.94M versus 535.2K). Which is the better fit depends on your goals.

CENTSMLE
Market Cap
2.34T302.66B
Volume
535.2K13.94M
Lot
5.35K139.35K
Turnover
39.66M1.79B
Average Price
74.1128.36
Value
39.66M1.79B
Indicative Equilibrium Price
74128
Indicative Equilibrium Volume
52717

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CENT
View details
SMLE
View details

About Centratama Telekomunikasi Indonesia Tbk.

PT Centratama Telekomunikasi Indonesia Tbk formerly Centrin Online The corporate was established on February 11th 1987 in Bandung as PT. Centrindo Utama. Since the first establishment, corporate focus the business on the information technology. Start the operation in computer hardware sales such as supporting hardware and monitor which produced by PT. Central Rama Informatiko as a affiliated company. And start the internet service provider business on 1996.

Read more on CENT

About Sinergi Multi Lestarindo Tbk.

PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.

Read more on SMLE